RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,538,672 | -5.2% | 2,318,813 | +6.6% | 0.00% | 0.0% |
| Q2 2023 | $40,662,103 | +2.0% | 2,174,444 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $39,850,768 | +5.7% | 2,171,704 | +14.1% | 0.00% | 0.0% |
| Q4 2022 | $37,689,795 | -24.1% | 1,903,525 | -7.7% | 0.00% | -50.0% |
| Q3 2022 | $49,627,000 | +32.2% | 2,062,659 | +0.3% | 0.00% | +100.0% |
| Q2 2022 | $37,533,000 | -5.3% | 2,056,583 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $39,623,000 | -40.1% | 1,801,860 | +0.0% | 0.00% | -50.0% |
| Q4 2021 | $66,167,000 | +12.2% | 1,801,469 | -5.1% | 0.00% | 0.0% |
| Q3 2021 | $58,957,000 | +15.3% | 1,898,821 | +18.0% | 0.00% | +100.0% |
| Q2 2021 | $51,141,000 | +65.6% | 1,608,662 | +15.6% | 0.00% | 0.0% |
| Q1 2021 | $30,888,000 | +13.0% | 1,391,280 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $27,335,000 | -28.6% | 1,383,981 | +16.4% | 0.00% | 0.0% |
| Q3 2020 | $38,300,000 | +15.5% | 1,189,443 | +4.1% | 0.00% | 0.0% |
| Q2 2020 | $33,173,000 | +189.1% | 1,143,139 | +111.9% | 0.00% | 0.0% |
| Q1 2020 | $11,475,000 | +604.9% | 539,471 | +814.9% | 0.00% | – |
| Q4 2019 | $1,628,000 | – | 58,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |